About ACE Pharmaceuticals
ACE Pharmaceuticals is a Healthcare company based in Zeewolde (Netherlands) founded in 1990, and was acquired by Quadrum Capital in January 2021. Drugs are manufactured for sister companies in the Netherlands. ACE Pharmaceuticals offers products and services including Registered Products, Apotheek Bereidingen, Zelfzorgproducten, and Clinical Trial Medication. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Protozoan. Its legal entity is Ace Pharmaceuticals BV.
Company details
ACE Pharmaceuticals was founded in 1990 and is based in Zeewolde, Netherlands. Operations focus on the pharmaceutical sector, where drugs are produced exclusively for sister companies Orphan Drugs NL and ARTECEF. Tropical medicines, including antimalarials, are made for ARTECEF, while orphan drugs are manufactured for Orphan Drugs NL. The company maintains a specialized role in contract manufacturing within the European pharmaceutical industry.
- Headquarters Zeewolde, Netherlands
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website ace-pharm.nl
- Acquired by Quadrum Capital (Jan 2021)
- Legal Name Ace Pharmaceuticals Bv
- InvestorsColesco
& 3 more
- Acquired byQuadrum Capital
(Jan 2021)
Products & Services of ACE Pharmaceuticals
ACE Pharmaceuticals offers a comprehensive portfolio of products and services, including Registered Products, Apotheek Bereidingen, Zelfzorgproducten, and Clinical Trial Medication.
Officially registered medicines for general use and distribution.
Tailored pharmaceutical compounds for specific patient requirements.
Over-the-counter products for everyday health needs.
Medications produced for clinical research and trials.
Funding Insights of ACE Pharmaceuticals
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of ACE Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | Private Equity Round | – | – |
4 investors in total: 4 institutional.
Investors in ACE Pharmaceuticals
ACE Pharmaceuticals has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Colesco, Rivean Capital and Gilde Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Colesco is recognized as a private credit specialist in Europe. | colescocapital.com | Utrecht, Netherlands | ||
Private equity and accelerator investments are directed toward multiple sectors. | riveancapital.com | Brussels, Belgium | ||
Private equity and venture captial firm focused on healthcare sectors | gildehealthcare.com | Cambridge, United States | ||
Quadrum Capital is engaged in supporting entrepreneurial ventures. | quadrum-capital.nl | Almelo, Netherlands |
Investor details for ACE Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ACE Pharmaceuticals
3 dated milestones of ACE Pharmaceuticals across 35 years, from founding to its latest funding, stage changes and deals.
- Founded ACE Pharmaceuticals is founded.
- Exit Acquired by Quadrum Capital.
- Funding First funding round.
Web traffic of ACE Pharmaceuticals
The website of ACE Pharmaceuticals (ace-pharm.nl) receives about 4.1K visits a month and ranks #5,772,996 among all websites worldwide, #6,244 in Biotechnology and Pharmaceuticals.
- Monthly visits4.1K
▲ 50.8% vs previous month
- Unique visitors1.1K
per month
- Global rank#5,772,996
among all websites
- Category rank#6,244
Health · Biotechnology and Pharmaceuticals
- Bounce rate32%
- Pages per visit1.9
- Average visit27 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with ACE Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fagron.com | 100% | 55K | #629,618 | View details | |
| apotheekkennisbank.nl | 60% | 24.8K | #1,263,289 | View details | |
generic.co.za | generic.co.za | 52% | #1,418,918 | – | |
apotheek.nl | apotheek.nl | 48% | #38,928 | – | |
magis-pharma.be | magis-pharma.be | 48% | #691,286 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for ACE Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ace Pharmaceuticals
Complete news archive for ACE Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACE Pharmaceuticals
ACE Pharmaceuticals was founded in 1990 and raised its 1st funding round 35 years after it was founded.
ACE Pharmaceuticals is headquartered in Zeewolde, Netherlands. It is registered at Zeewolde, Flevoland, Netherlands.
ACE Pharmaceuticals was founded in 1990 and is based in Zeewolde, Netherlands. Operations focus on the pharmaceutical sector, where drugs are produced exclusively for sister companies Orphan Drugs NL and ARTECEF. Tropical medicines, including antimalarials, are made for ARTECEF, while orphan drugs are manufactured for Orphan Drugs NL. The company maintains a specialized role in contract manufacturing within the European pharmaceutical industry.
ACE Pharmaceuticals offers Registered Products, Apotheek Bereidingen, Zelfzorgproducten, and Clinical Trial Medication.
ACE Pharmaceuticals has 4 investors. Key investors include Colesco, Rivean Capital, Gilde Healthcare, and Quadrum Capital.
ACE Pharmaceuticals operates through Ace Pharmaceuticals Bv.
Yes. ACE Pharmaceuticals was acquired by Quadrum Capital in January 2021.